People · Operator
Named in public records as an officer, director or promoter · active 2020–2021 · Biotechnology, Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Deep Apple Therapeutics, Inc. | — | Biotechnology | Series A | $5.0M | $90.7M | 2021 |
| Red Queen Therapeutics, Inc. | — | Biotechnology | Series A | $5.0M | $97.4M | 2021 |
| Nine Square Therapeutics Corp | — | Biotechnology | Series A | $4.2M | $151.8M | 2020 |
| Initial Therapeutics, Inc. | — | Biotechnology | Seed | $3.8M | $168.6M | 2020 |
| Evercrisp Biosciences, Inc. | — | Biotechnology | Seed | $3.5M | $84.0M | 2021 |
| Apertor Pharmaceuticals, Inc. | — | Pharmaceuticals | Seed | $3.0M | $95.3M | 2020 |
Spiros Liras at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Spiros Liras on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Seth Harrison | 6 | 19 |
| Michael Ehlers | 3 | 6 |
| Paul Da Silva Jardine | 2 | 3 |
| MATTHEW JACOBSON | 1 | 6 |
| Paul Eisenberg | 1 | 2 |
| Brian Shoichet | 1 | 2 |
| Anna Batarina | 1 | 2 |
| Loren Walensky | 1 | 2 |
| James H. Doudna Cate | 1 | 1 |
| Rajesh H. Chopra | 1 | 1 |
| Edmund Graziani | 1 | 1 |
| Robert T. Abraham | 1 | 1 |
| Tanja Kortemme | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.